Late Breaking News
BETHESDA, MD — Research rooted in treating trauma in the civilian sector is examining how a combination of pharmaceuticals and virtual reality can help combat veterans recover more swiftly from chronic PTSD.
WASHINGTON — Veterans with PTSD are more likely than others to be prescribed opioids for post-injury pain, and that can lead to an increase in adverse mental and physical effects, according to a recent VA study.
WASHINGTON — According to VA statistics, four out of 10 veterans with mental-health challenges seek assistance from clergy — more than all other types of mental-health providers combined.
WASHINGTON — After American Indian and Alaska Native veterans initially tried telemental health services, their use of any health services significantly increased, as did the proportion receiving psychotropic medication, a new study found.1
WASHINGTON — Continuing a pattern of easing the way for Gulf War veterans to seek care and compensation, VA has extended the presumptive period for them to file claims for benefits for previously undiagnosed illnesses.
WASHINGTON — Frustrated by the numerous reports of veterans unable to receive timely mental healthcare at VA facilities, legislators have called for the VA Office of the Inspector General to conduct a formal audit of wait times.
WASHINGTON — Reports about suicide prevention constantly focus on the difficulty veterans have in receiving mental healthcare, even though the suicide rate is dropping.
WASHINGTON — Veterans with mental illness and substance abuse cost nearly three times as much to treat as the average veteran. According to a VA-commissioned study by the RAND Corp. looking at data from one year of care (2007), such veterans represented 15% of patients using VA healthcare services, but accounted for 32.9% of costs.
WASHINGTON — Diet impacts far more than waistlines and the risk of obesity. In fact, the military has been paying close attention to not only the role of nutrition in maintaining physical health, but also how it relates to psychological health issues such as suicide and even TBI.
WASHINGTON — An antipsychotic medication commonly used by VA to treat combat-related PTSD has been found to have no discernible benefit. Patients taking the drug risperidone (Risperdal) did no better than those taking a placebo, according to a recent VA-run study.
Most Popular Stories
- Many Healthcare Providers Lose VA Retention Bonuses
- Federal Medicine Organizational Meetings — Tarred with the Same Brush?
- Despite Formulary, High-Cost Diabetes Drug Use Varies Widely Across VA Facilities
- Report Says Administration Faces Hard Choices For Veterans Programs
- Physician Overcomes TBI to Return to Active-Duty Medicine
Join Our E-Mail List